Home Chen Dakai Elected Vice Chairman of Nantong Biopharmaceutical Enterprises Overseas Chinese Federation; Kekai Life Sciences Advances with Minimally Invasive Cardiac Repair Technologies

Chen Dakai Elected Vice Chairman of Nantong Biopharmaceutical Enterprises Overseas Chinese Federation; Kekai Life Sciences Advances with Minimally Invasive Cardiac Repair Technologies

Dec 17, 2025 16:26 CST Updated 16:26
Kokai Life Sciences

Developer, Manufacturer, and Distributor in the Field of Structural Heart Disease

Image

Click the blue words to follow us

Image





Image
Image
Image
Image
Image


On the afternoon of December 11, the establishment of the Nantong Biomedical Enterprises Overseas Chinese Federation Workstation and the First Representative Assembly was successfully held at Dongbuzhou Science City, Haimen High-tech Zone, Haimen District. The meeting elected the first group of leading members on-site. Among them, Chen Dakai, Chairman of Kokai (Nantong) Life Sciences Co., Ltd., was elected as the Vice Chairman of the Nantong Biomedical Enterprises Overseas Chinese Federation. He will work with other members to pool the wisdom and strength of overseas Chinese to contribute to the high-quality development of Nantong's biomedical industry.


Image


Kokai (Nantong) Life Sciences Co., Ltd., specializing in the research and development of medical devices for structural heart disease, has brought good news to numerous heart disease patients with its innovative repair technology that is minimally invasive and does not require opening the chest. With profound accumulation and extensive influence in the industry, Chen Dakai's election will further strengthen the connection between the Overseas Chinese Federation and biopharmaceutical enterprises, injecting new vitality into the deep integration of resources from the Overseas Chinese community and the industrial chain.

It is reported that the establishment of the Nantong Biomedical Enterprise Overseas Chinese Federation Workstation is a concrete practice of the Municipal Overseas Chinese Federation in response to the municipal Party committee's deployment to "build a highland for the transformation of biopharmaceutical achievements in the Yangtze River Delta." Going forward, the workstation will focus on three core tasks: ideological guidance, industrial collaboration, and service for overseas Chinese. Under the leadership of Zou Ping as the head and Chen Dakai and others as members of the leadership team, the workstation will continue to promote the deep integration of overseas Chinese resources with the industry chain, injecting strong momentum from the overseas Chinese community into writing a new chapter in the modernization of building a strong, prosperous, beautiful, and advanced new Nantong.





About Kokai

Image

Kokai (Nantong) Life Sciences Co., Ltd. was established in September 2018. It is a high-end biopharmaceutical technology enterprise that integrates the research and development, production, and sales of medical devices in the field of structural heart disease, developing systematic solutions for valve diseases targeting different populations, needs, and scenarios. The company's technical team is primarily composed of R&D personnel who have returned from the United States and Germany, with many years of development and research experience in cardiac medical fields. Their technical level is leading in China and synchronized with the advanced frontiers of global cardiac medicine.


The company has been honored with:

2024 Hurun Global Gazelle Companies List

2024 Hurun China Medical New Forces Enterprises

2023 Hurun Global Cheetah Companies List

Top 100 Emerging Medical Device Companies in China 2023

2023 Future Healthcare 100 Strong List "Top 100 China Innovative Medical Devices"

Innovation Star of the 2022 Outstanding Contribution to Scientific and Technological Innovation Award in the Northern High-Tech Zone of the City

2022 KPMG China's Second Biotech Innovation 50

2022 China Investment Healthcare VENTURE50 List